Wikiwand AI

Velagliflozin

Medication From Wikipedia, the free encyclopedia

Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.[2][4][5] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.[6] It is taken by mouth.[2]

Trade namesSenvelgo
License data
Quick facts Clinical data, Trade names ...
Velagliflozin
Clinical data
Trade namesSenvelgo
License data
Routes of
administration
By mouth
ATCvet code
Legal status
Legal status
Identifiers
  • 2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H25NO5
Molar mass395.455 g·mol−1
3D model (JSmol)
  • N#Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(C2CC2)cc1
  • InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1
  • Key:SENUNDCNOYAWGN-ZQGJOIPISA-N
  • Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N
Close

Medical uses

Velagliflozin is indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.[2][4][6]

References

Related Articles

Timelines

Top Qs

Fact Checks